McDermott International Seminar 2017 | Focus on Korea | McDermott Skip to main content

McDermott International Seminar 2017 | Focus on Korea

Überblick


The Trump Administration’s Enforcement Priorities

What Korean companies need to know about the new US government’s approach towards antitrust, Foreign Corrupt Practices Act (FCPA) and Intellectual Property (IP) rights enforcement

We are pleased to invite you to join us for McDermott International Seminar 2017 | Focus on Korea: The Trump Administration’s Enforcement Priorities.

The impact of President Trump’s election continues to be felt in the US and around the world. What do the changes in leadership and policy priorities at the US Justice Department (DOJ) mean for Korean companies, especially those that do business in the United States? Should companies expect a different approach towards compliance and enforcement?

The presentation, with the head of McDermott’s Silicon Valley litigation/white collar practice group and a former DOJ senior official, will cover the following issues:

  • The Trump Administration’s DOJ leadership changes;
  • Antitrust enforcement trends of interest to companies in Korea;
  • FCPA enforcement trends;
  • The DOJ’s IP rights enforcement trends, including recent efforts to combat economic espionage (state-sponsored trade secret theft).

CLE credit is pending in California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states.

For more information and to RSVP, please contact Annie Song – phone: 82 02 6030 3611.

Mehr erfahren

Tokyo, Japan / In-person / January 17, 2024

2024 McDermott International Seminar in Japan

Webinar / Externe Vorträge / November 15, 2022

ABA Antitrust Section Corporate Compliance Monthly Update

Düsseldorf, Germany / Externe Vorträge / September 18, 2019

Düsseldorfer Kartellrechtspanel: Verhandeln von Kartellschadensersatzforderungen

New York, New York / Externe Vorträge / December 5-6, 2017

22nd Annual Conference on Drug & Medical Device Litigation